Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
What Patients Evaluating AOD 9604 Typically Report Timeline to first changes: Most published protocols note 4 to 6 weeks before body composition changes become measurable Areas of change: Visceral and subcutaneous fat reduction, with particular effect reported in the abdominal region in some subjects Energy and recovery: Some participants in clinical and investigational settings report improved energy and exercise recovery, though this is not a primary mechanism of the peptide What it is not: AOD 9604 does not cause rapid dramatic weight loss the way GLP-1 medications can in the first few months
FDA said it did not appear on the 503B bulks list and was not eligible for the compounding exemptions discussed in that letter
Potential Side Effects: Be aware of potential side effects associated with specific peptides
Glut-4 Translocation: Researching improved glucose uptake and the reduction of fasting insulin levels in metabolic syndrome models
